BTG3 and systemic lupus erythematosus: In clinical practice, some patients with SLE have been treated with glucocorticoids and immunosuppressants for an extended period; however, their serum ANA titers have consistently remained high, while the levels of anti-dsDNA antibody and complement have failed to normalize despite stable disease manifestations.